Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-02-12

FDA Approved: SYMDEKO — Original Application (Vertex Pharmaceuticals Incorporated)

View source ↗

Summary

FDA approved SYMDEKO (tezacaftor and ivacaftor) as the original application for the treatment of cystic fibrosis. This action represents the original approval o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Symdeko (tezacaftor/ivacaftor)

Snippet

ORIG AP for SYMDEKO (TEZACAFTOR AND IVACAFTOR)